Richard F. Little, M.D.

Richard F. Little, M.D.

  • Center for Cancer Research
  • National Cancer Institute
HIV and AIDS Malignancy Branch


Dr. Little joined the NCI's Cancer Therapy and Evaluation Program (CTEP) as head of the therapeutics section for Hematologic and AIDS-related Cancers and Hematopoietic Stem Cell in April 2007.  His focus is to oversee, review, and coordinate the NCI-sponsored phase III cancer treatment trials in these diseases in an effort to promote practice-changing and definitive clinical trials.

Dr. Little's research interests have focused on immune suppression-related neoplastic disease, investigation of viral targets for oncolytic therapy and immunotherapy, and antiangiogenesis.

For more information about Dr. Little, visit his CTEP website.

Areas of Expertise

1) hematologic cancers, 2) AIDS-related cancers